Searching across hundreds of databases

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Resource Name
RRID:SCR_004006 RRID Copied      
PDF Report How to cite
Towards novel translational safety biomarkers for adverse drug toxicity (RRID:SCR_004006)
Copy Citation Copied
Resource Information

URL: http://www.tipharma.com/pharmaceutical-research-projects/predictive-drug-disposition-and-toxicology-research/adr-safety-biomarkers.html

Proper Citation: Towards novel translational safety biomarkers for adverse drug toxicity (RRID:SCR_004006)

Description: Consortium to develop novel in vitro predictive screening tools and in vivo translational models and biomarkers to improve adverse drug reaction (ADR) hazard identification. This project studies the metabolic effects of eight drugs (among which are paracetamol and diclofenac ) with known side effects in the liver. By looking into the mechanics on a level ranging from the molecule to the patient, the researchers in this project aim to find biomarkers and develop tools for the early prediction of side effects of drugs. One of the breakthroughs in the project is the discovery that a person''''s genetic profile appears to be one of the mechanics that have an influence on the resistance to adverse drug reactions. The ability to identify adverse effects in an early stage will prevent much discomfort in patients and economic loss. Several PhD theses have been written from this project.

Abbreviations: ADR Research,

Synonyms: ADR Safety Biomarkers, Adverse Drug Reaction Research

Resource Type: portal, consortium, organization portal, data or information resource

Keywords: biomarker, drug development, adverse drug reaction, in vitro, in vivo, screening tool, translational model, drug, liver, side effect, thesis, paracetamol, diclofenac, genetic profile, gene, safety

Expand All
This resource

is listed by

Consortia-pedia

is related to

Abbott Diagnostics

has parent organization

TI Pharma

Usage and Citation Metrics

We found {{ ctrl2.mentions.total_count }} mentions in open access literature.

We have not found any literature mentions for this resource.

We are searching literature mentions for this resource.

Most recent articles:

{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})

Checkfor all resource mentions.

Collaborator Network

A list of researchers who have used the resource and an author search tool

Find mentions based on location


{{ ctrl2.mentions.errors.location }}

A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.

Ratings and Alerts

No rating or validation information has been found for Towards novel translational safety biomarkers for adverse drug toxicity.

No alerts have been found for Towards novel translational safety biomarkers for adverse drug toxicity.

Data and Source Information